头颈癌放疗患者的决策后悔:患病率与相关因素
这项横断面观察研究纳入192例接受根治性放疗的头颈癌患者,采用决策后悔量表(DRS)评估。结果显示39%报告高度决策后悔,决策后悔与健康相关生活质量(HRQoL)、心理痛苦、焦虑、抑郁及癌症进展恐惧(FoP)相关,多因素回归中较差ECOG状态、较低HRQoL和较高FoP与决策后悔独立相关。
要点
- 39%的头颈癌放疗患者报告高度决策后悔(DRS>25分)。
- 决策后悔与较低HRQoL、较高心理痛苦、焦虑、抑郁及FoP相关。
- 多因素回归中较差ECOG状态、较低HRQoL和较高FoP与决策后悔相关。
核心结论
- 超过三分之一的头颈癌患者报告高度决策后悔,需加强共享决策以减轻决策后悔。
研究设计与样本
- 横断面观察研究,纳入接受根治性放疗的头颈癌患者,300例符合条件中192例参与并完成决策后悔量表(DRS)。
主要发现
- 27%无决策后悔(0分),34%轻度后悔(1-25分),39%高度后悔(>25分)。
- 放疗、全身治疗和手术的DRS平均(SD)得分分别为23.6(22.4)、20.8(19.3)和20.9(22.2)。
- 决策后悔与HRQoL(r=-0.34,p<0.001)、心理痛苦(r=0.25,p<0.001)、焦虑(r=0.20,p<0.01)、抑郁(r=0.19,p<0.01)及FoP(r=0.29,p<0.001)相关。
- 多因素回归中,较差ECOG状态(β=0.18,p<0.01)、较低HRQoL(β=-0.22,p<0.01)和较高FoP(β=0.19,p<0.05)与决策后悔相关。
临床怎么用
- 在头颈癌放疗决策中应强化共享决策,关注ECOG状态较差、HRQoL较低和FoP较高的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Head-and-neck cancer patients often face decisions between treatment options with similar oncological outcomes. In this context, decision regret becomes a central concern, particularly within the framework of shared decision-making. This study aims to assess the prevalence of decision regret and identify associated risk factors among head-and-neck cancer patients. METHODS: This cross-sectional observational study included patients who underwent curative radiotherapy for head-and-neck cancer. Decision regret was assessed using the Decision Regret Scale (DRS). Additional patient-reported outcomes included health-related quality of life (HRQoL), psychological distress, anxiety, depression, and fear of cancer progression (FoP). RESULTS: Of 300 eligible patients, 192 participated and filled out the DRS. The median age was 59 years (IQR, 45-65), and the median time between the end of radiotherapy and study participation was 45.5 months (IQR, 24-68.5). No decision regret (0 points) in terms of radiotherapy was reported by 27 %, mild regret (1-25 points) by 34 %, and high regret (>25 points) by 39 %. The mean (SD) DRS score regarding radiotherapy, systemic treatment, and surgery was 23.6 (22.4), 20.8 (19.3), and 20.9 (22.2), respectively. Decision regret was associated with HRQoL (r = -0.34, p < 0.001), distress (r = 0.25, p < 0.001), anxiety (r = 0.20, p < 0.01), depression (r = 0.19, p < 0.01), and FoP (r = 0.29, p < 0.001). In the multiple regression, a poorer ECOG status (β = 0.18, p < 0.01), lower HRQoL (β = -0.22, p < 0.01), and higher FoP (β = 0.19, p < 0.05) were associated with decision regret. CONCLUSIONS: More than one-third of head-and-neck cancer patients report high decision regret. These findings highlight the need for enhanced shared decision-making to mitigate decision regret in head-and-neck oncology.
引用
- Tews AM, Hinz A, Magnus V, et al. Decision regret in patients with head-and-neck cancer undergoing radiotherapy. Clin Transl Radiat Oncol. 2025. PMID: 40673135. doi:10.1016/j.ctro.2025.101005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。